The Java Community Process formally launches development of Java SE 28, with Project Valhalla once again positioned as the release's most closely watched feature.

Bandai Namco has lost another major pillar of the fighting game community. Kohei Ikeda (Nakatsu) officially resigned from the studio on June 1, 2026. He served as the Game Director for Tekken 7 and ...

Apple today confirmed that watchOS 27 will not support the Apple Watch Series 8, Apple Watch Ultra (first generation), or Apple Watch SE (second generation), effectively drawing a line at devices ...

If you haven't seen the latest Java developer productivity report from Perforce, you should check it out. Written by Perforce CTO Rod Cope and developer tools exec Jeff Michael, the "2025 Java ...

Sharla Boehm earned a teaching degree from the University of California, Los Angeles, before she channeled her talent for math into computer programming. While working at the RAND Corporation, she ...

Dimensions (mm) 291.80 x 189.10 x 6.90 211.58 x 125.48 x 8.80 ...

Samantha Lord began her Valnet career in 2021 when she joined CBR as a Movies/TV Junior Editor. After also joining the training team, she was invited to lead the Movies/TV team as a Deputy Editor.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. 'Ace Combat' series director Kazutoki Kono (left) and friend (right). With Ace Combat 8 on ...

Publisher Bandai Namco and developer Bandai Namco Aces have released an eight-minute developer diary for Ace Combat 8: Wings of Theve. In this developer diary video from Project Aces, we’ll take a ...

Don't miss the Developer Diary for Ace Combat 8: Wings of Theve, the upcoming installment to the action dogfighting game developed by Bandai Namco Aces. Players will hear straight from the developers ...

BISMARCK, N.D.--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) announced today that it has acquired SE&M Constructors, Inc., SE&M of the Triangle, Inc. and SECO Rentals, LLC (collectively SE&M ...

Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in its largest deal since 2020, the biopharma company said on Monday, as it looks to strengthen its lineup of cancer ...